https://www.lavo.ai/ | United States | 2022 | $0.5M
Lavo Life Sciences is a U.S.-based startup specializing in AI-accelerated crystal structure prediction for the pharmaceutical industry. The company offers software solutions to help drug development teams reduce turnaround time, minimize risk, and optimize solid-state formulations of small molecule drugs. Founded in 2022, Lavo Life Sciences is backed by venture capital investors and its key individuals include co-founders with PhDs in computational chemistry and a former Google Cloud product manager. The company primarily serves the pharmaceutical sector with its AI-powered technology for predicting drug molecule crystal structures.
